Sign in with Google
|
USD 46.96
Price
-0.36
(-0.76%)
Day Change
|
|
|---|
HALO, the overall quality is good (Quality = 77) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
In details, quality factors are ok , financial health is not good , and ability to make profit is good , ...
| Quality Factors |
|
61% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 16 |
| Magic Formula Rank by ROA |
354
|
| Magic Formula Rank by ROE |
354
|
| Magic Formula Rank by ROIC |
382
|
| Price | 46.96 |
| PBV / Sector |
13.19 / 1.56
|
| Earning Per Share | 3.02 |
| PE / Sector |
15.67 / 16.11
|
| PEG or PE/Growth / Sector |
-2.50 / 5.60
|
| Average 1M Daily Value |
79.39 M
|
| Average 1W Daily Value |
113.19 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
77% |
| Return to Investors |
|
12% |
| Registration Details |
| Analyze Date | 2024-12-21 07:38:41 |
| Symbol | HALO |
| Name | HALOZYME THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 127.23 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 6,020.38 / 3,466.05 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
EXEL 
RPRX 
UTHR 
